| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...853855K |
| P356 | DOI | 10.1371/JOURNAL.PONE.0053855 |
| P932 | PMC publication ID | 3567087 |
| P698 | PubMed publication ID | 23408933 |
| P5875 | ResearchGate publication ID | 235621943 |
| P50 | author | Tadafumi Kato | Q37378746 |
| P2093 | author name string | An-a Kazuno | |
| Yuji Okazaki | |||
| Hiroko Sugawara | |||
| Kaori Otsuki | |||
| Kenji Ohtawa | |||
| Masaya Usui | |||
| P2860 | cites work | Duration of untreated illness and suicide in bipolar disorder: a naturalistic study. | Q51860686 |
| Structure of yeast phosphoglycerate mutase | Q59092628 | ||
| Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder | Q60440984 | ||
| Lithium chloride alters cytoskeletal organization in growing, but not mature, cultured chick sensory neurons | Q68246205 | ||
| Twin studies of affective illness | Q68288753 | ||
| The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia | Q81481442 | ||
| Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder | Q24655630 | ||
| Comparing protein abundance and mRNA expression levels on a genomic scale | Q24682985 | ||
| Correlation between protein and mRNA abundance in yeast | Q28137554 | ||
| Whole-genome association study of bipolar disorder | Q28271419 | ||
| Mitochondrial dysfunction in bipolar disorder | Q30640247 | ||
| Postmortem changes in the level of brain proteins. | Q30650273 | ||
| Dihydropyrimidinase related protein-2 as a biomarker for temperature and time dependent post mortem changes in the mouse brain proteome | Q31027132 | ||
| Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis | Q33237100 | ||
| Gene expression profiling of lymphoblastoid cell lines from monozygotic twins discordant in severity of autism reveals differential regulation of neurologically relevant genes | Q33243918 | ||
| Apolipoprotein A-I as a candidate serum marker for the response to lithium treatment in bipolar disorder. | Q33785105 | ||
| Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium | Q33902752 | ||
| Anatomy of bipolar disorder and schizophrenia: a meta-analysis. | Q34092580 | ||
| Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder | Q34105528 | ||
| Neuroplasticity and cellular resilience in mood disorders | Q34111006 | ||
| Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia | Q34137363 | ||
| Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival. | Q34156394 | ||
| Genetic or epigenetic difference causing discordance between monozygotic twins as a clue to molecular basis of mental disorders | Q34556925 | ||
| PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers | Q34622380 | ||
| Neuroprotective effects of lithium in cultured cells and animal models of diseases. | Q34692758 | ||
| Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders | Q34994209 | ||
| Hypermethylation of serotonin transporter gene in bipolar disorder detected by epigenome analysis of discordant monozygotic twins. | Q35844206 | ||
| Proteomic approaches in brain research and neuropharmacology | Q35908585 | ||
| The utility of biomarker discovery approaches for the detection of disease mechanisms in psychiatric disorders | Q37056209 | ||
| Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder | Q37203365 | ||
| The neuroproteomics of schizophrenia. | Q37796059 | ||
| Impaired mitochondrial function in psychiatric disorders | Q38003304 | ||
| The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth | Q38299684 | ||
| Expression profiling in monozygotic twins discordant for bipolar disorder reveals dysregulation of the WNT signalling pathway. | Q38302646 | ||
| Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder | Q38350959 | ||
| Serotonergic dysfunction in depression | Q38754759 | ||
| Glycogen metabolism and glycolytic enzymes | Q39893059 | ||
| Norepinephrine in depressive reactions. A review | Q40028374 | ||
| Mechanisms of altered Ca2+ signalling in transformed lymphoblastoid cells from patients with bipolar disorder | Q40618969 | ||
| Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness | Q43509323 | ||
| The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects | Q43744085 | ||
| Inhibition of tubulin assembly and covalent binding to microtubular protein by valproic acid glucuronide in vitro | Q44158856 | ||
| Post-mortem interval effects on the phosphorylation of signaling proteins | Q44362502 | ||
| Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions | Q44735796 | ||
| Paliperidone as a mood stabilizer: a pre-frontal cortex synaptoneurosomal proteomics comparison with lithium and valproic acid after chronic treatment reveals similarities in protein expression | Q46460865 | ||
| 2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease | Q46661063 | ||
| A Danish Twin Study of Manic-Depressive Disorders | Q46959031 | ||
| Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis | Q47890327 | ||
| Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins | Q48182410 | ||
| Subgenual prefrontal cortex abnormalities in mood disorders | Q48725544 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | e53855 | |
| P577 | publication date | 2013-02-07 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Proteomic analysis of lymphoblastoid cells derived from monozygotic twins discordant for bipolar disorder: a preliminary study | |
| P478 | volume | 8 |
| Q36043355 | A composite peripheral blood gene expression measure as a potential diagnostic biomarker in bipolar disorder |
| Q91717242 | A logical relationship for schizophrenia, bipolar, and major depressive disorder. Part 1: Evidence from chromosome 1 high density association screen |
| Q33733254 | A novel relationship for schizophrenia, bipolar and major depressive disorder Part 5: a hint from chromosome 5 high density association screen |
| Q38222164 | Biomarkers in major depressive disorder: the role of mass spectrometry |
| Q39252963 | Discordant twins as a tool to unravel the aetiology of bipolar disorder. |
| Q92193007 | Protein Biomarkers in Major Depressive Disorder: An Update |
| Q38939217 | Proteomics insight into psychiatric disorders: an update on biological fluid biomarkers. |
| Q30009461 | Search for peripheral biomarkers in patients affected by acutely psychotic bipolar disorder: a proteomic approach |
| Q28083512 | What Have Mass Spectrometry-Based Proteomics and Metabolomics (Not) Taught Us about Psychiatric Disorders? |
Search more.